Literature DB >> 17485221

Quality of life during 18 months after coronary artery bypass grafting.

Pertti Loponen1, Michael Luther, Jan-Ola Wistbacka, Kari Korpilahti, Jari Laurikka, Harri Sintonen, Heini Huhtala, Matti R Tarkka.   

Abstract

OBJECTIVE: The aim of the present study was to evaluate the change in health related quality of life (HRQoL) among elective coronary artery bypass grafting (CABG) patients.
METHODS: A total of 302 CABG patients were included in the study. Complete pre-, peri- and postoperative data were collected comprehensively in a database. HRQoL was measured by the 15D instrument. The 15D is a non-disease-specific, 15-dimensional, standardized and self-administered measure of HRQoL that can be used both as a profile and single index score measure. Baseline assessment was carried out before coronary angiography and assessment was repeated 6 and 18 months after surgery. Data were analysed by gender and in three age groups, i.e. patients <65 years, 65-74 years and > or = 75 years.
RESULTS: Thirty day mortality was 1.0%, and the survival rate at 6 and 18 months was 99.0% and 96.7%, respectively. Preoperative HRQoL of CABG patients was lower in comparison to age- and gender-standardized Finnish population (P<0.001). HRQoL of the patients improved significantly after CABG and the positive change lasted over the whole observation period, despite a slight decrease of 15D scores until 18 months. Although male patients had a higher preoperative HRQoL than women (P=0.005), both genders benefited similarly from the operation. In the patients > or = 75 years, the initial improvement of HRQoL returned to the preoperative level 18 months after the surgery.
CONCLUSIONS: CABG patients experience a significant improvement in their HRQoL within 6 months after the operation and the effect remains through a mid-term observation time. However, expectations of improved HRQoL may have a limited value in decision making for surgery of coronary artery disease (CAD) for patients more than 75 years old.

Entities:  

Mesh:

Year:  2007        PMID: 17485221     DOI: 10.1016/j.ejcts.2007.03.045

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  6 in total

Review 1.  Does coronary artery bypass grafting improve quality of life in elderly patients?

Authors:  Kamran Baig; Leanne Harling; Joseph Papanikitas; Saina Attaran; Hutan Ashrafian; Roberto Casula; Thanos Athanasiou
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-05-27

2.  Speed and quality in coronary artery bypass graft (CABG) surgery: is there a connection?

Authors:  Juha-Matti Lehtonen; Mikko Hippeläinen; Eija Kattainen; Juhani Kouri; Jaakko Kujala
Journal:  Health Care Manag Sci       Date:  2009-06

3.  Predicting adverse cardiovascular outcomes in post-coronary artery bypass grafting patients using novel ECG frequency analysis of the QRS complex.

Authors:  Thalia Hua; Alexandra Vlahos; Mohammad Hassan Shariat; Darrin Payne; Damian Redfearn
Journal:  Ann Noninvasive Electrocardiol       Date:  2021-03-22       Impact factor: 1.468

4.  Impact of post-hospital cardiac rehabilitation on the quality of life of patients after surgical treatment for coronary artery disease.

Authors:  Józefa Dąbek; Ewelina Pyka; Joanna Piotrkowicz; Krystian Stachoń; Grażyna Bonek-Wytrych
Journal:  Kardiochir Torakochirurgia Pol       Date:  2017-06-30

5.  Does CABG with Saphenous Vein Grafting and Standard Cardiac Rehabilitation Affect Lower Limb Function? A Clinical Study.

Authors:  Aleksandra Skomudek; Grzegorz Waz; Krystyna Rozek-Piechura
Journal:  Int J Environ Res Public Health       Date:  2019-05-29       Impact factor: 3.390

6.  Determinants of non-recovery in physical health-related quality of life one year after cardiac surgery: a prospective single Centre observational study.

Authors:  Hilda Rijnhart-de Jong; Jo Haenen; Goris Bol Raap; Lilian Jekel; Tessel Vossenberg; Olga Bondarenko; Christiaan Boerma
Journal:  J Cardiothorac Surg       Date:  2020-09-01       Impact factor: 1.637

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.